Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Interaction between warfarin and propafenone in healthy volunteer subjects.

Kates RE, Yee YG, Kirsten EB.

Clin Pharmacol Ther. 1987 Sep;42(3):305-11.

PMID:
3621785
2.

The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.

Niopas I, Toon S, Aarons L, Rowland M.

Eur J Clin Pharmacol. 1999 Jul;55(5):399-404.

PMID:
10456491
3.

Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.

Bjornsson TD, Meffin PJ, Swezey S, Blaschke TF.

J Pharmacol Exp Ther. 1979 Sep;210(3):316-21.

PMID:
480183
4.

Interaction between propranolol and propafenone in healthy volunteers.

Kowey PR, Kirsten EB, Fu CH, Mason WD.

J Clin Pharmacol. 1989 Jun;29(6):512-7.

PMID:
2754020
5.

Pharmacokinetics and pharmacodynamics of warfarin at steady state.

Routledge PA, Chapman PH, Davies DM, Rawlins MD.

Br J Clin Pharmacol. 1979 Sep;8(3):243-7.

6.

Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarin.

Ermer JC, Hicks DR, Wheeler SC, Kraml M, Jusko WJ.

Clin Pharmacol Ther. 1994 Mar;55(3):305-16.

PMID:
8143396
7.

Norfloxacin does not alter warfarin's disposition or anticoagulant effect.

Rocci ML Jr, Vlasses PH, Distlerath LM, Gregg MH, Wheeler SC, Zing W, Bjornsson TD.

J Clin Pharmacol. 1990 Aug;30(8):728-32.

PMID:
2401751
8.

Drug interaction between propafenone and metoprolol.

Wagner F, Kalusche D, Trenk D, Jähnchen E, Roskamm H.

Br J Clin Pharmacol. 1987 Aug;24(2):213-20.

9.

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.

O'Reilly RA, Trager WF, Rettie AE, Goulart DA.

Clin Pharmacol Ther. 1987 Sep;42(3):290-4.

PMID:
3621782
10.

Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.

Williams RL, Schary WL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M.

Clin Pharmacol Ther. 1976 Jul;20(1):90-7.

PMID:
1277729
11.

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.

Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD.

J Clin Pharmacol. 1995 Oct;35(10):1008-15.

PMID:
8568008
12.
13.

The effect of furosemide and bumetanide on warfarin metabolism and anticoagulant response.

Nilsson CM, Horton ES, Robinson DS.

J Clin Pharmacol. 1978 Feb-Mar;18(2-3):91-4.

PMID:
624779
14.

Spironolactone and warfarin interaction.

O'Reilly RA.

Clin Pharmacol Ther. 1980 Feb;27(2):198-201.

PMID:
7353340
15.

Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

O'Reilly RA, Trager WF, Motley CH, Howald W.

J Clin Invest. 1980 Mar;65(3):746-53.

16.

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.

Ragueneau-Majlessi I, Levy RH, Meyerhoff C.

Epilepsy Res. 2001 Nov;47(1-2):55-63.

PMID:
11673021
17.

Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.

Miller JW, Skerjanec A, Knadler MP, Ghosh A, Allerheiligen SR.

Pharm Res. 2001 Jul;18(7):1024-8.

PMID:
11496940
18.

Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.

Wingard LB Jr, O'Reilly RA, Levy G.

Clin Pharmacol Ther. 1978 Feb;23(2):212-7.

PMID:
620483
19.

Inhibitory effects of propafenone on the pharmacokinetics of caffeine in humans.

Michaud V, Mouksassi MS, Labbé L, Bélanger PM, Ferron LA, Gilbert M, Grech-Bélanger O, Turgeon J.

Ther Drug Monit. 2006 Dec;28(6):779-83.

PMID:
17164694
20.

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.

Chan E, McLachlan A, O'Reilly R, Rowland M.

Clin Pharmacol Ther. 1994 Sep;56(3):286-94.

PMID:
7924124

Supplemental Content

Support Center